CN103041117B - Traditional Chinese medicine composition for treating tuberculous exadative pleurisy - Google Patents
Traditional Chinese medicine composition for treating tuberculous exadative pleurisy Download PDFInfo
- Publication number
- CN103041117B CN103041117B CN201210596799.6A CN201210596799A CN103041117B CN 103041117 B CN103041117 B CN 103041117B CN 201210596799 A CN201210596799 A CN 201210596799A CN 103041117 B CN103041117 B CN 103041117B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- pleurisy
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating tuberculous exadative pleurisy. Traditional Chinese medicine believes that the tuberculous exadative pleurisy is mainly caused by qi dysfunction of a lung, a spleen and a kidney. Therefore, tussilago, mulberry bark, snakegourd fruits, rust-coloured crotalaria herb with roots, szechwan-yunnan sanicle root, kelp, securidaca inappendiculata hassk, trogopterus dung, herba lycopi, fingered citron, bighead atractylodes rhizome, allium macrostemon, poria cocos, Chinese yam, walnut kernels, Lanjiang lily bulbs and honey which can strengthen a spleen, tonify a kidney, clear away lung-heat, tonify qi and disinhibit water are adopted and prepared into decoction by a preparation room of our hospital; and through clinical trials, the composition has a total effective rate of 97.2% and low side effects, and the treatment cost is low.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, relate in particular to a kind of Chinese medicine composition for the treatment of tuberculous exadative pleurisy.
Background technology
Tuberculous exadative pleurisy is a kind of clinical common tuberculosis, this disease course of disease is long, state of an illness complexity, the general traditional treatment time is long, because tuberculosis died 92% finds to merge Pleural Lesions, at present both at home and abroad conventional antitubercular agent is combined and is used hormone therapy tuberculous pleuritis, the refractory causing due to irregular medication in recent years and the tuberculosis of former drug-fast bacteria infection increase gradually, in tuberculous pleurisy patients method, people to be sought efficiently, safety, the Therapeutic Method of alternative antitubercular agent, as short-term injection hormone in thoracic cavity, antitubercular agent and vasodilation medicine, external application Chinese medicinal ointment etc., but these Therapeutic Method all exist curative effect undesirable, the problem that side effect is large.I am by clinical research discovery for many years, and treatment by Chinese herbs has stable curative effect, can reduce toxic and side effects and the untoward reaction of Western medicine.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of tuberculous exadative pleurisy.Motherland's medical science thinks that tuberculous exadative pleurisy is mainly due to lung, spleen, kidney three visceral-qi malfunctions, the suitable strengthening spleen, tonifying kidney lung heat clearing of Chinese traditional treatment for this reason, supplementing QI to induce diuresis.
The object of the invention is to be achieved through the following technical solutions, the Chinese medicine composition of this treatment tuberculous exadative pleurisy is made up of the Chinese medicine of following weight portion: Flos Farfarae 10-15 part, Cortex Mori 9-11 part, Fructus Trichosanthis 7-9 part, Herba Crotalariae Ferrugineae 15-20 part, Radix Saniculae Astrantifoliae 13-15 part, Thallus Laminariae (Thallus Eckloniae) 12-14 part, Radix securidacae 18-20 part, Oletum Trogopterori 9-11 part, Herba Lycopi 6-8 part, Fructus Citri Sarcodactylis 10-12 part, Rhizoma Atractylodis Macrocephalae 7-9 part, Bulbus Allii Macrostemonis 11-13 part, Poria 5-7 part, Rhizoma Dioscoreae 18-20 part, Semen Juglandis 15-17 part, Bulbus lilii lankongensis 3-5 part, Mel 5-7 part.
Preferably, 12 parts of Flos Farfaraees, 10 parts of Cortex Mori, 8 parts of Fructus Trichosanthis, 18 parts of Herba Crotalariae Ferrugineaes, 14 parts of Radix Saniculae Astrantifoliae, 13 parts of Thallus Laminariae (Thallus Eckloniae)s, 19 parts of Radix securidacae, 10 parts of Oletum Trogopteroris, 7 parts of Herba Lycopi, 11 parts of Fructus Citri Sarcodactylis, 8 parts of the Rhizoma Atractylodis Macrocephalaes, 12 parts of Bulbus Allii Macrostemonis, 6 parts, Poria, 19 parts of Rhizoma Dioscoreaes, 16 parts of Semen Juglandis, 4 parts of Bulbus lilii lankongensiss, 6 parts of Mel.
Preparation method is made decoction by above-mentioned Chinese medicine by traditional method.
In side: the cough-relieving of Flos Farfarae moistening the lung and resolving phlegm; Cortex Mori eliminating pathogen from the lung for relieving asthma, inducing diuresis to remove edema; Fructus Trichosanthis removing heat-phlegm, relieving stuffiness of the chest by dispersing aggregation of pathogens, moistens just unimpeded; The Herba Crotalariae Ferrugineae gas of astringing the lung, spleen reinforcing kidney, diuresis, detumescence poison; Radix Saniculae Astrantifoliae invigorating the lung and the kidney; Thallus Laminariae (Thallus Eckloniae), Oletum Trogopterori, Radix securidacae, Herba Lycopi's eliminating phlegm and softening indurated mass, inducing diuresis to remove edema; Fructus Citri Sarcodactylis dispersing the stagnated live-QI to relieve the stagnation of QI, regulating the flow of Qi and the middle Jiao, drying dampness to eliminate phlegm; Rhizoma Atractylodis Macrocephalae air making-up and spleen enlivening, dampness diuretic; Bulbus Allii Macrostemonis activating YANG and eliminating stagnation, circulation of qi promoting intestinal stasis relieving; Poria promoting diuresis to eliminate damp pathogen, spleen-benefiting mind-tranquilizing; Rhizoma Dioscoreae spleen reinforcing nourishing the stomach, the lung benefiting that promotes the production of body fluid, the kidney invigorating arresting seminal emission; Semen Juglandis the kidney invigorating, warming the lung, intestine moistening; Bulbus lilii lankongensis nourishing the lung to arrest cough, heat clearing and tranquillizing; The invigorating middle warmer of Mel QI invigorating, expelling phlegm for arresting cough, alleviates pain relieving.
Clinical data
This group of physical data case 70 examples, are the tuberculous exadative pleurisy patient of medical the court of in February, 2007~2009 year November, wherein, and male 38 examples, female's 32 examples, 15~80 years old age; A small amount of hydrops 14 examples, moderate hydrops 40 examples, a large amount of hydrops 16 examples; In 70 examples, tuberculosis is just controlled 44 examples, control again 26 examples, simple tuberculous exadative pleurisy 46 examples, wherein, merge tuberculous peritonitis 4 examples, merge tuberculous pericarditis 6 examples, merge limitation pneumothorax 2 examples, merge mediastinal pleurisy 4 examples, merge empty active tuberculosis 8 examples in lung, merge hematogenous spread pulmonary tuberculosis 2 examples; In 70 examples, merge 4 type diabetes 6 examples, sick 6 examples of complicated hypertension, merge arrhythmia 4 examples, merge digestive tract ulcer 6 examples, hormone therapy failure 4 examples.
The routine patient of Therapeutic Method 70 takes the above Chinese medicine preparation, every day potion, every day 3 times, early, middle and late sub-service; It within one week, is a course for the treatment of.
Curative effect determinate standard: the tuberculous exadative pleurisy curative effect determinate standard of drafting with reference to national tuberculosis meeting in 1987, (1) cures: transference cure, x-ray chest film inspection lesions showed absorbs completely, and ultrasound diagnosis is without hydrothorax, and expectorant bacterium is turned out cloudy; (2) effective: symptom alleviates, x-ray chest films showed pathological changes absorbs and takes a turn for the better, and the chamber hydrops of ultrasound diagnosis is below 300~500ml; (3) invalid: symptom is without improvement, and expectorant acid-fast bacilli is cultivated, x-ray inspection shows substantially identical with before treatment, and ultrasound diagnosis is without changing or worsening.
Therapeutic outcome (1) treatment is added up curative effect after two courses for the treatment of, and 70 routine patients wherein cure 55 examples and account for 78.6% in two weeks, and in surrounding, effective 13 examples account for 18.6%, and invalid 2 examples account for 2.9%; Total effective rate 97.2%.
In (2) 70 routine patients two weeks, absorb 32 examples completely and account for 45.7%, in surrounding, all cases all absorbs completely; After in eight weeks, there is not hydrothorax and pachynsis pleurae in check again.
The specific embodiment
Embodiment mono-: take Flos Farfarae 12g, Cortex Mori 10g, Fructus Trichosanthis 8g, Herba Crotalariae Ferrugineae 18g, Radix Saniculae Astrantifoliae 14g, Thallus Laminariae (Thallus Eckloniae) 13g, Radix securidacae 19g, Oletum Trogopterori 10g, Herba Lycopi 7g, Fructus Citri Sarcodactylis 11g, Rhizoma Atractylodis Macrocephalae 8g, Bulbus Allii Macrostemonis 12g, Poria 6g, Rhizoma Dioscoreae 19g, Semen Juglandis 16g, Bulbus lilii lankongensis 4g, Mel 7g, make decoction by traditional method, every day potion, every day 3 times, early, middle and late sub-service.
Embodiment bis-: take Flos Farfarae 10g, Cortex Mori 9g, Fructus Trichosanthis 7g, Herba Crotalariae Ferrugineae 15g, Radix Saniculae Astrantifoliae 13g, Thallus Laminariae (Thallus Eckloniae) 12g, Radix securidacae 18g, Oletum Trogopterori 9g, Herba Lycopi 6g, Fructus Citri Sarcodactylis 10g, Rhizoma Atractylodis Macrocephalae 7g, Bulbus Allii Macrostemonis 11g, Poria 7g, Rhizoma Dioscoreae 18g, Semen Juglandis 15g, Bulbus lilii lankongensis 3g, Mel 5g, make decoction by traditional method, every day potion, every day 3 times, early, middle and late sub-service.
Embodiment tri-: take Flos Farfarae 15g, Cortex Mori 11g, Fructus Trichosanthis 9g, Herba Crotalariae Ferrugineae 20g, Radix Saniculae Astrantifoliae 15g, Thallus Laminariae (Thallus Eckloniae) 14g, Radix securidacae 20g, Oletum Trogopterori 11g, Herba Lycopi 8g, Fructus Citri Sarcodactylis 12g, Rhizoma Atractylodis Macrocephalae 9g, Bulbus Allii Macrostemonis 13g, Poria 5g, Rhizoma Dioscoreae 20g, Semen Juglandis 17g, Bulbus lilii lankongensis 5g, Mel 7g, make decoction by traditional method, every day potion, every day 3 times, early, middle and late sub-service.
Claims (2)
1. treat a Chinese medicine composition for tuberculous exadative pleurisy, it is characterized in that this Chinese medicine composition is made up of the Chinese medicine of following weight portion: Flos Farfarae 10-15 part, Cortex Mori 9-11 part, Fructus Trichosanthis 7-9 part, Herba Crotalariae Ferrugineae 15-20 part, Radix Saniculae Astrantifoliae 13-15 part, Thallus Laminariae (Thallus Eckloniae) 12-14 part, Radix securidacae 18-20 part, Oletum Trogopterori 9-11 part, Herba Lycopi 6-8 part, Fructus Citri Sarcodactylis 10-12 part, Rhizoma Atractylodis Macrocephalae 7-9 part, Bulbus Allii Macrostemonis 11-13 part, Poria 5-7 part, Rhizoma Dioscoreae 18-20 part, Semen Juglandis 15-17 part, Bulbus lilii lankongensis 3-5 part, Mel 5-7 part.
2. a kind of Chinese medicine composition for the treatment of tuberculous exadative pleurisy according to claim 1, is characterized in that this Chinese medicine composition is made up of the Chinese medicine of following weight portion: 12 parts of Flos Farfaraees, 10 parts of Cortex Mori, 8 parts of Fructus Trichosanthis, 18 parts of Herba Crotalariae Ferrugineaes, 14 parts of Radix Saniculae Astrantifoliae, 13 parts of Thallus Laminariae (Thallus Eckloniae)s, 19 parts of Radix securidacae, 10 parts of Oletum Trogopteroris, 7 parts of Herba Lycopi, 11 parts of Fructus Citri Sarcodactylis, 8 parts of the Rhizoma Atractylodis Macrocephalaes, 12 parts of Bulbus Allii Macrostemonis, 6 parts, Poria, 19 parts of Rhizoma Dioscoreaes, 16 parts of Semen Juglandis, 4 parts of Bulbus lilii lankongensiss, 6 parts of Mel.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210596799.6A CN103041117B (en) | 2012-12-28 | 2012-12-28 | Traditional Chinese medicine composition for treating tuberculous exadative pleurisy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210596799.6A CN103041117B (en) | 2012-12-28 | 2012-12-28 | Traditional Chinese medicine composition for treating tuberculous exadative pleurisy |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103041117A CN103041117A (en) | 2013-04-17 |
CN103041117B true CN103041117B (en) | 2014-06-11 |
Family
ID=48054128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210596799.6A Expired - Fee Related CN103041117B (en) | 2012-12-28 | 2012-12-28 | Traditional Chinese medicine composition for treating tuberculous exadative pleurisy |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103041117B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104784537A (en) * | 2013-12-23 | 2015-07-22 | 范巧兰 | Traditional Chinese medicine composition for treating tuberculous pleurisy |
CN105998899A (en) * | 2016-06-22 | 2016-10-12 | 岳宁宁 | Traditional Chinese medicine composition for treating exudative pleurisy |
CN105902911A (en) * | 2016-06-25 | 2016-08-31 | 丁常燕 | Traditional Chinese medicine composition for treating wet pleurisy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101019918A (en) * | 2007-03-08 | 2007-08-22 | 贵州大学 | Natural antibiotic composition extracted from rust-colored crotalaria herb and its extraction process |
CN101934041A (en) * | 2010-09-10 | 2011-01-05 | 重庆市南川区金佛山中药材品种培育研究所 | Chinese medicinal herb for treating pleurisy |
-
2012
- 2012-12-28 CN CN201210596799.6A patent/CN103041117B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN103041117A (en) | 2013-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103041117B (en) | Traditional Chinese medicine composition for treating tuberculous exadative pleurisy | |
CN102988832B (en) | Traditional Chinese medicine composition used for treating asthma of children | |
CN102451354A (en) | Preparation method for Chinese medicine for treating acute pancreatitis | |
CN102697984B (en) | Chinese medicinal external application preparation for treating acute mastitis | |
CN101700381A (en) | Pill for healing hepatitis B and softening liver | |
CN102872397B (en) | Traditional Chinese medicine composition for treating chronic cystitis | |
CN102499977B (en) | Traditional Chinese medicine preparation for treating children bronchopneumonia | |
CN102784296B (en) | Fructus trichosanthis oral liquid | |
CN101693095B (en) | Traditional Chinese medicine preparation for treating cirrhosis and liver ascites | |
CN103566158A (en) | Traditional Chinese medicine composition used for curing viral myocarditis | |
CN102671146B (en) | Herbal decoction for curing chronic sinusitis | |
CN100457177C (en) | Chinese medicinal health-care preparation for cloaring lung, supplementing kidney | |
CN103520474A (en) | Traditional Chinese medicinal preparation for treating viral myocarditis | |
CN103893332A (en) | Traditional Chinese medicine for treating gastritis | |
CN101181500B (en) | Externally used medicament for curing respiratory system disease and preparation method thereof | |
CN107961355A (en) | A kind of navel ball for treating liver ascites and preparation method thereof | |
CN101181509B (en) | Chinese medicine prescription orally taken for curing pulmonary emphysema | |
CN102139062A (en) | Novel traditional Chinese medicine for treating pharyngitis and tonsillitis | |
CN106074746A (en) | A kind of medicine treating respiratory tract disease and preparation method thereof | |
CN104491703A (en) | Oral traditional Chinese medicine composition for treating traumatic synovitis of knee joint | |
CN103845384A (en) | Traditional Chinese medicine for treating tuberculous pleurisy | |
CN102641374B (en) | Traditional Chinese decoction for treating chronic bronchitis | |
CN102000312A (en) | Traditional Chinese medicinal formula for treating enteritis and gastropathy | |
CN108478725A (en) | A kind of Chinese medicine preparation and preparation method thereof for treating poultry influenza | |
CN105749124A (en) | Chinese medicine composition for treating postpartum fever |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140611 Termination date: 20141228 |
|
EXPY | Termination of patent right or utility model |